Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine-Reference-Cited by-同舟云学术

Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine

Published:2016-01-25 Issue:1 Volume:23 Page:
ISSN:1423-0127
Container-title:Journal of Biomedical Science
language:en
Short-container-title:J Biomed Sci

Author:

Gableh Fateme,Saeidi Mohsen,Hemati Shaghayegh,Hamdi Kasra,Soleimanjahi Hoorieh,Gorji Ali,Ghaemi Amir

Funder

Research Deputy at Golestan Medical University

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Biochemistry (medical),Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1186/s12929-016-0238-3

Reference39 articles.

1. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121(3):621–32. PubMed Epub 2007/04/04. eng.

2. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048–56. PubMed Epub 2010/10/19. eng.

3. Kumar S, Biswas M, Jose T. HPV vaccine: Current status and future directions. Med J Armed Forces India. 2015;71(2):171–7. PubMed Pubmed Central PMCID: PMC4388981, Epub 2015/04/11. eng.

4. Bahrami AA, Ghaemi A, Tabarraei A, Sajadian A, Gorji A, Soleimanjahi H. DNA vaccine encoding HPV-16 E7 with mutation in L-Y-C-Y-E pRb-binding motif induces potent anti-tumor responses in mice. J Virol Methods. 2014;206:12–8. PubMed Epub 2014/06/01. eng.

5. Tahamtan A, Ghaemi A, Gorji A, Kalhor HR, Sajadian A, Tabarraei A, et al. Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems. J Biomed Sci. 2014;21:69. PubMed Pubmed Central PMCID: PMC4237815, Epub 2014/08/01. eng.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status and future directions for the development of human papillomavirus vaccines;Frontiers in Immunology;2024-06-25

2. The HPV viral regulatory mechanism of TLRs and the related treatments for HPV-associated cancers;Frontiers in Immunology;2024-05-15

3. Combining toll-like receptor agonists with immune checkpoint blockade affects antitumor vaccine efficacy;Journal for ImmunoTherapy of Cancer;2024-05

4. Exploring the causal association between rheumatoid arthritis and the risk of cervical cancer: a two-sample Mendelian randomization study;Arthritis Research & Therapy;2024-01-23

5. Toll-like receptor agonists as cancer vaccine adjuvants;Human Vaccines & Immunotherapeutics;2023-12-28